Medsearch   Report issue

For profit Phase 3
Founded: St Paul MN United States (1936)
Status: No NME R&D (1936)

Organization Overview

First Clinical Trial
2000
NCT00014339
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2000

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 3 Trials (3)

melphalan (alkeran) (1 trial)

prednisone (meticorten) (1 trial)

wobe-mugos e (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Multiple Myeloma (Phase 3)

Neoplasms, Plasma Cell (Phase 3)

Plasmacytoma (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 3